Richard J Hawkins Lumos Pharma, Inc. (LUMO) insider trading activity

Richard J Hawkins is Chief Executive Officer of LUMOS PHARMA, INC.. Currently has a direct ownership of 753,093 shares of LUMO, which is worth approximately $1.75 Million. The most recent transaction as insider was on Apr 01, 2024, when has been sold 1,522 shares (Common Stock) at a price of $2.84 per share, resulting in proceeds of $4,322. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 753K

0.4% 3M change

0.3% 12M change

Total Value Held $1.75 Million

Richard J Hawkins Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 01 2024	SELL Payment of exercise price or tax liability	$4,322 $2.84 p/Share	1,522 Reduced 0.2%	753,093 Common Stock
Apr 01 2024	BUY Grant, award, or other acquisition	$12,780 $2.84 p/Share	4,500 Added 0.59%	754,615 Common Stock
Feb 01 2024	SELL Payment of exercise price or tax liability	$2,076 $3.01 p/Share	690 Reduced 0.09%	750,115 Common Stock
Apr 01 2023	SELL Payment of exercise price or tax liability	$5,037 $3.31 p/Share	1,522 Reduced 0.2%	750,805 Common Stock
Feb 01 2023	SELL Payment of exercise price or tax liability	$1,464 $3.52 p/Share	416 Reduced 0.06%	752,327 Common Stock
Feb 01 2023	BUY Grant, award, or other acquisition	$15,840 $3.52 p/Share	4,500 Added 0.59%	752,743 Common Stock
Apr 01 2022	SELL Payment of exercise price or tax liability	$13,531 $9.23 p/Share	1,466 Reduced 0.2%	748,243 Common Stock

Feb 01 2022	SELL Payment of exercise price or tax liability	$1,733 $10.02 p/Share	173 Reduced 0.02%	749,709 Common Stock
Feb 01 2022	BUY Grant, award, or other acquisition	$45,090 $10.02 p/Share	4,500 Added 0.6%	749,882 Common Stock
Apr 01 2021	SELL Payment of exercise price or tax liability	$18,644 $12.25 p/Share	1,522 Reduced 0.2%	745,382 Common Stock
Feb 01 2021	BUY Grant, award, or other acquisition	-	2,329 Added 0.31%	746,904 Common Stock

Also insider at

SVRA

Savara Inc Healthcare

Director

PSTV

PLUS THERAPEUTICS, INC. Healthcare

RJH